Surgical management of Benign Prostatic Hyperplasia: Transvesical prostatectomy versus Transurethral resection of prostate with a volume range of 70–100 gram

Adnan Mohammed  Kanoos; Mohammed Elswalem

المؤلفون

Adnan Mohammed Kanoos Misrata Medical Center (MMC) Libya
Mohammed Elswalem Misrata Medical Center (MMC) Libya

الكلمات المفتاحية:

Transvesical، prostatectomy، monopolar، transurethral، resection

الملخص

Objectives: This study aims to compare the short-term outcomes and complications of transvesical prostatectomy versus monopolar transurethral resection of the prostate between 70 and 100 grams.

Methods and material: This is a retrospective descriptive study conducted from April 2017 to April 2021. A total of 59 patients were admitted and underwent transvesical prostatectomy (TVP) and transurethral resection of the prostate (TURP) at Misrata Medical Center (department of urology). Patients with prostatic volume between 70-100 g were included in this study, while patients with prostatic volume greater than 100 g or less than 70 g were excluded. Types of surgery (TVP and TURP), patient age, size of the prostate gland, duration of surgery (mins), blood transfusion, clot retention, length of catheterization (days), hospital stay (days), post-operative infection, incontinence, reoperation, bladder neck stenosis, and urethral stricture were analyzed.

المراجع

Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet. 2003;361(9366):1359-67.

Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl. 1989;2:33-50.

McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12(12):897-906.

Foo KT. Pathophysiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017;4(3):152-7.

Lepor H. Pathophysiology of benign prostatic hyperplasia in the aging male population. Rev Urol. 2005;7 Suppl 4(Suppl 4):S3-s12.

Kopp W. Diet-Induced Hyperinsulinemia as a Key Factor in the Etiology of Both Benign Prostatic Hyperplasia and Essential Hypertension? Nutr Metab Insights. 2018;11:1178638818773072.

Kim HJ, Park JW, Cho YS, Cho CH, Kim JS, Shin HW, et al. Pathogenic role of HIF-1α in prostate hyperplasia in the presence of chronic inflammation. Biochim Biophys Acta. 2013;1832(1):183-94.

Lloyd GL, Ricke WA, McVary KT. Inflammation, Voiding and Benign Prostatic Hyperplasia Progression. J Urol. 2019;201(5):868-70.

Hawtrey CE, Williams RD. Historical evolution of transurethral resection at the University of Iowa: Alcock and Flocks. J Urol. 2008;180(1):55-61.

McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-803.

Ahmed Gadam I, Nuhu A, Aliyu S. Ten-year experience with open prostatectomy in maiduguri. ISRN Urol. 2012;2012:406872.

Freyer PJ. A Clinical Lecture on Total Extirpation of the Prostate for Radical Cure of Enlargement of that Organ: With Four Successful Cases: Delivered at the Medical Graduates' College, London, June 26th. Br Med J. 1901;2(2116):125-9.

Lin Y, Wu X, Xu A, Ren R, Zhou X, Wen Y, et al. Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. World J Urol. 2016;34(9):1207-19.

Alhasan SU, Aji SA, Mohammed AZ, Malami S. Transurethral resection of the prostate in Northern Nigeria, problems and prospects. BMC Urol. 2008;8:18.

Ugwumba FO, Ozoemena OF, Okoh AD, Echetabu KN, Mbadiwe OM. Transvesical prostatectomy in the management of benign prostatic hyperplasia in a developing country. Niger J Clin Pract. 2014;17(6):797-801.

Simforoosh N, Abdi H, Kashi AH, Zare S, Tabibi A, Danesh A, et al. Open prostatectomy versus transurethral resection of the prostate, where are we standing in the new era? A randomized controlled trial. Urol J. 2010;7(4):262-9.

Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006;50(5):969-79; discussion 80.

Gupta S, Solanki M, Maharaul HH. A Comparative Study of Post Operative Complications of Open Prostatectomy (Fryer’s) Versus Trans Urethral Resection of Prostate. International Journal of Biomedical Research. 2015;6:712.

Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53(1):160-6.

Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol. 2006;49(6):961-9.

Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol. 2009;56(5):798-809.

Varkarakis I, Kyriakakis Z, Delis A, Protogerou V, Deliveliotis C. Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology. 2004;64(2):306-10.

Ottaiano N, Shelton T, Sanekommu G, Benson CR. Surgical Complications in the Management of Benign Prostatic Hyperplasia Treatment. Curr Urol Rep. 2022;23(5):83-92.

Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58(3):384-97.

Würnschimmel E, Lipsky H. [Urethral stricture after TURP and transvesical prostatectomy]. Urologe A. 1992;31(6):374-7.

Jepsen JV, Bruskewitz RC. Recent developments in the surgical management of benign prostatic hyperplasia. Urology. 1998;51(4A Suppl):23-31.

Tubaro A, Carter S, Hind A, Vicentini C, Miano L. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia. J Urol. 2001;166(1):172-6.

Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how? Eur Urol. 1999;36 Suppl 3:7-13.

Fried NM. New laser treatment approaches for benign prostatic hyperplasia. Curr Urol Rep. 2007;8(1):47-52.

Kuntz RM. Laser treatment of benign prostatic hyperplasia. World J Urol. 2007;25(3):241-7.

Mayer EK, Kroeze SG, Chopra S, Bottle A, Patel A. Examining the 'gold standard': a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate (TURP) outcomes. BJU Int. 2012;110(11):1595-601.

Balbay MD, Ergen A, Sahin A, Lekili M, Ulucay S, Karaağaoğlu E. Development of urethral stricture after transurethral prostatectomy: a retrospective study. Int Urol Nephrol. 1992;24(1):49-53.

Oranusi CK, Nwofor A, Oranusi IO. Complication rates of open transvesical prostatectomy according to the Clavien-Dindo classification system. Niger J Clin Pract. 2012;15(1):34-7.

Clarke A, Rosen R. Length of stay. How short should hospital care be? Eur J Public Health. 2001;11(2):166-70